ID   OSBL1_HUMAN             Reviewed;         950 AA.
AC   Q9BXW6; B7Z7D3; Q9BZF5; Q9NW87;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   27-MAR-2002, sequence version 2.
DT   07-APR-2021, entry version 185.
DE   RecName: Full=Oxysterol-binding protein-related protein 1;
DE            Short=ORP-1;
DE            Short=OSBP-related protein 1;
GN   Name=OSBPL1A; Synonyms=ORP1, OSBP8, OSBPL1, OSBPL1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS A AND B), AND VARIANT PRO-810.
RX   PubMed=11735225; DOI=10.1006/geno.2001.6663;
RA   Jaworski C.J., Moreira E., Li A., Lee R., Rodriguez I.R.;
RT   "A family of 12 human genes containing oxysterol-binding domains.";
RL   Genomics 78:185-196(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM A).
RX   PubMed=11279184; DOI=10.1074/jbc.m101204200;
RA   Xu Y., Liu Y., Ridgway N.D., McMaster C.R.;
RT   "Novel members of the human oxysterol-binding protein family bind
RT   phospholipids and regulate vesicle transport.";
RL   J. Biol. Chem. 276:18407-18414(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM B), AND GENE FAMILY.
RX   PubMed=11483621;
RA   Lehto M., Laitinen S., Chinetti G., Johansson M., Ehnholm C., Staels B.,
RA   Ikonen E., Olkkonen V.M.;
RT   "The OSBP-related protein family in humans.";
RL   J. Lipid Res. 42:1203-1213(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 514-790 (ISOFORM A).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16177791; DOI=10.1038/nature03983;
RA   Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D.,
RA   Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X.,
RA   Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J.,
RA   Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L.,
RA   Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A.,
RA   Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C.,
RA   Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K.,
RA   Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R.,
RA   Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 18.";
RL   Nature 437:551-555(2005).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH RAB7A.
RX   PubMed=16176980; DOI=10.1091/mbc.e05-03-0189;
RA   Johansson M., Lehto M., Tanhuanpaeae K., Cover T.L., Olkkonen V.M.;
RT   "The oxysterol-binding protein homologue ORP1L interacts with Rab7 and
RT   alters functional properties of late endocytic compartments.";
RL   Mol. Biol. Cell 16:5480-5492(2005).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   FUNCTION.
RX   PubMed=17428193; DOI=10.1042/bj20070176;
RA   Suchanek M., Hynynen R., Wohlfahrt G., Lehto M., Johansson M., Saarinen H.,
RA   Radzikowska A., Thiele C., Olkkonen V.M.;
RT   "The mammalian oxysterol-binding protein-related proteins (ORPs) bind 25-
RT   hydroxycholesterol in an evolutionarily conserved pocket.";
RL   Biochem. J. 405:473-480(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [11]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-499, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH MOSPD2, SUBCELLULAR
RP   LOCATION, DOMAIN, FFAT MOTIF, AND MUTAGENESIS OF 476-PHE--TYR-477.
RX   PubMed=29858488; DOI=10.15252/embr.201745453;
RA   Di Mattia T., Wilhelm L.P., Ikhlef S., Wendling C., Spehner D., Nomine Y.,
RA   Giordano F., Mathelin C., Drin G., Tomasetto C., Alpy F.;
RT   "Identification of MOSPD2, a novel scaffold for endoplasmic reticulum
RT   membrane contact sites.";
RL   EMBO Rep. 19:0-0(2018).
CC   -!- FUNCTION: Binds phospholipids; exhibits strong binding to phosphatidic
CC       acid and weak binding to phosphatidylinositol 3-phosphate (By
CC       similarity). Stabilizes GTP-bound RAB7A on late endosomes/lysosomes and
CC       alters functional properties of late endocytic compartments via its
CC       interaction with RAB7A (PubMed:16176980). Binds 25-hydroxycholesterol
CC       and cholesterol (PubMed:17428193). {ECO:0000250,
CC       ECO:0000269|PubMed:16176980, ECO:0000269|PubMed:17428193}.
CC   -!- SUBUNIT: Interacts with VAPA (By similarity). Interacts with the GTP-
CC       bound form of RAB7A (PubMed:17081983). Interacts with OAS1B (By
CC       similarity). Interacts (via FFAT motif) with MOSPD2 (via MSP domain)
CC       (PubMed:29858488). {ECO:0000250|UniProtKB:Q8K4M9,
CC       ECO:0000250|UniProtKB:Q91XL9, ECO:0000269|PubMed:17081983,
CC       ECO:0000269|PubMed:29858488}.
CC   -!- INTERACTION:
CC       Q9BXW6; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-765918, EBI-16439278;
CC       Q9BXW6; Q8NHP6: MOSPD2; NbExp=8; IntAct=EBI-765918, EBI-2812848;
CC       Q9BXW6; P51149: RAB7A; NbExp=5; IntAct=EBI-765918, EBI-1056089;
CC       Q9BXW6; Q9P0L0: VAPA; NbExp=4; IntAct=EBI-765918, EBI-1059156;
CC       Q9BXW6; O95292: VAPB; NbExp=5; IntAct=EBI-765918, EBI-1188298;
CC   -!- SUBCELLULAR LOCATION: Late endosome {ECO:0000269|PubMed:16176980,
CC       ECO:0000269|PubMed:29858488}. Note=Colocalizes with RAB7A, RAB9A and
CC       LAMP1 in late endosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=B; Synonyms=OSBPL1B, OSBP8L, ORP1L;
CC         IsoId=Q9BXW6-1; Sequence=Displayed;
CC       Name=A; Synonyms=OSBPL1A, OSBP8S;
CC         IsoId=Q9BXW6-2; Sequence=VSP_003779;
CC       Name=4;
CC         IsoId=Q9BXW6-4; Sequence=VSP_045443;
CC   -!- DOMAIN: The FFAT motif is required for interaction with MOSPD2.
CC       {ECO:0000269|PubMed:29858488}.
CC   -!- SIMILARITY: Belongs to the OSBP family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAG53407.2; Type=Miscellaneous discrepancy; Note=Unlikely isoform. Aberrant splice sites.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF392449; AAL40662.1; -; mRNA.
DR   EMBL; AF392450; AAL40663.1; -; mRNA.
DR   EMBL; AF274714; AAK15154.1; -; mRNA.
DR   EMBL; AF323726; AAG53407.2; ALT_SEQ; mRNA.
DR   EMBL; AK001079; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK301862; BAH13569.1; -; mRNA.
DR   EMBL; AC023983; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC090772; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   CCDS; CCDS11884.1; -. [Q9BXW6-1]
DR   CCDS; CCDS11885.1; -. [Q9BXW6-2]
DR   CCDS; CCDS56056.1; -. [Q9BXW6-4]
DR   RefSeq; NP_001229437.1; NM_001242508.1. [Q9BXW6-4]
DR   RefSeq; NP_060500.3; NM_018030.4. [Q9BXW6-2]
DR   RefSeq; NP_542164.2; NM_080597.3. [Q9BXW6-1]
DR   RefSeq; XP_016881022.1; XM_017025533.1. [Q9BXW6-2]
DR   RefSeq; XP_016881023.1; XM_017025534.1.
DR   PDB; 5ZM5; X-ray; 2.60 A; A=534-950.
DR   PDB; 5ZM6; X-ray; 2.70 A; A/B=524-950.
DR   PDB; 5ZM7; X-ray; 3.40 A; A=524-950.
DR   PDB; 6IYB; X-ray; 2.09 A; B/D=5-152.
DR   PDB; 6TQS; X-ray; 2.25 A; G/H/I/J/K=469-485.
DR   PDBsum; 5ZM5; -.
DR   PDBsum; 5ZM6; -.
DR   PDBsum; 5ZM7; -.
DR   PDBsum; 6IYB; -.
DR   PDBsum; 6TQS; -.
DR   SMR; Q9BXW6; -.
DR   BioGRID; 125379; 27.
DR   IntAct; Q9BXW6; 24.
DR   STRING; 9606.ENSP00000320291; -.
DR   SwissLipids; SLP:000001534; -.
DR   iPTMnet; Q9BXW6; -.
DR   PhosphoSitePlus; Q9BXW6; -.
DR   BioMuta; OSBPL1A; -.
DR   DMDM; 20143880; -.
DR   EPD; Q9BXW6; -.
DR   jPOST; Q9BXW6; -.
DR   MassIVE; Q9BXW6; -.
DR   MaxQB; Q9BXW6; -.
DR   PaxDb; Q9BXW6; -.
DR   PeptideAtlas; Q9BXW6; -.
DR   PRIDE; Q9BXW6; -.
DR   ProteomicsDB; 6854; -.
DR   ProteomicsDB; 79527; -. [Q9BXW6-1]
DR   ProteomicsDB; 79528; -. [Q9BXW6-2]
DR   Antibodypedia; 22086; 190 antibodies.
DR   Ensembl; ENST00000319481; ENSP00000320291; ENSG00000141447. [Q9BXW6-1]
DR   Ensembl; ENST00000357041; ENSP00000349545; ENSG00000141447. [Q9BXW6-4]
DR   Ensembl; ENST00000399443; ENSP00000382372; ENSG00000141447. [Q9BXW6-2]
DR   GeneID; 114876; -.
DR   KEGG; hsa:114876; -.
DR   UCSC; uc002kvd.5; human. [Q9BXW6-1]
DR   CTD; 114876; -.
DR   DisGeNET; 114876; -.
DR   GeneCards; OSBPL1A; -.
DR   HGNC; HGNC:16398; OSBPL1A.
DR   HPA; ENSG00000141447; Tissue enhanced (skeletal).
DR   MIM; 606730; gene.
DR   neXtProt; NX_Q9BXW6; -.
DR   OpenTargets; ENSG00000141447; -.
DR   PharmGKB; PA32826; -.
DR   VEuPathDB; HostDB:ENSG00000141447.16; -.
DR   eggNOG; KOG2209; Eukaryota.
DR   GeneTree; ENSGT00940000155295; -.
DR   HOGENOM; CLU_007105_5_1_1; -.
DR   InParanoid; Q9BXW6; -.
DR   OMA; EKAQICQ; -.
DR   OrthoDB; 863978at2759; -.
DR   PhylomeDB; Q9BXW6; -.
DR   TreeFam; TF320922; -.
DR   PathwayCommons; Q9BXW6; -.
DR   Reactome; R-HSA-192105; Synthesis of bile acids and bile salts.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation.
DR   BioGRID-ORCS; 114876; 6 hits in 995 CRISPR screens.
DR   ChiTaRS; OSBPL1A; human.
DR   GeneWiki; OSBPL1A; -.
DR   GenomeRNAi; 114876; -.
DR   Pharos; Q9BXW6; Tbio.
DR   PRO; PR:Q9BXW6; -.
DR   Proteomes; UP000005640; Chromosome 18.
DR   RNAct; Q9BXW6; protein.
DR   Bgee; ENSG00000141447; Expressed in corpus callosum and 242 other tissues.
DR   ExpressionAtlas; Q9BXW6; baseline and differential.
DR   Genevisible; Q9BXW6; HS.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IBA:GO_Central.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IBA:GO_Central.
DR   GO; GO:0044232; C:organelle membrane contact site; IDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IDA:BHF-UCL.
DR   GO; GO:0005543; F:phospholipid binding; NAS:UniProtKB.
DR   GO; GO:0032934; F:sterol binding; IBA:GO_Central.
DR   GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0008203; P:cholesterol metabolic process; NAS:UniProtKB.
DR   GO; GO:0016192; P:vesicle-mediated transport; NAS:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 2.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR037239; OSBP_sf.
DR   InterPro; IPR000648; Oxysterol-bd.
DR   InterPro; IPR018494; Oxysterol-bd_CS.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   PANTHER; PTHR10972; PTHR10972; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF01237; Oxysterol_BP; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 3.
DR   SMART; SM00233; PH; 1.
DR   SUPFAM; SSF144000; SSF144000; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 3.
DR   PROSITE; PS01013; OSBP; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ANK repeat; Coiled coil; Endosome;
KW   Lipid transport; Lipid-binding; Phosphoprotein; Reference proteome; Repeat;
KW   Transport.
FT   CHAIN           1..950
FT                   /note="Oxysterol-binding protein-related protein 1"
FT                   /id="PRO_0000100367"
FT   REPEAT          47..76
FT                   /note="ANK 1"
FT   REPEAT          80..109
FT                   /note="ANK 2"
FT   REPEAT          175..204
FT                   /note="ANK 3"
FT   DOMAIN          235..334
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   REGION          1..237
FT                   /note="Interaction with RAB7A"
FT                   /evidence="ECO:0000269|PubMed:16176980"
FT   COILED          430..463
FT                   /evidence="ECO:0000255"
FT   COILED          877..913
FT                   /evidence="ECO:0000255"
FT   MOTIF           469..483
FT                   /note="FFAT"
FT                   /evidence="ECO:0000269|PubMed:29858488"
FT   MOD_RES         499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:17081983,
FT                   ECO:0007744|PubMed:18669648, ECO:0007744|PubMed:20068231,
FT                   ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163"
FT   VAR_SEQ         1..513
FT                   /note="Missing (in isoform A)"
FT                   /evidence="ECO:0000303|PubMed:11279184,
FT                   ECO:0000303|PubMed:11735225, ECO:0000303|PubMed:14702039"
FT                   /id="VSP_003779"
FT   VAR_SEQ         1..382
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045443"
FT   VARIANT         810
FT                   /note="S -> P (in dbSNP:rs35693789)"
FT                   /evidence="ECO:0000269|PubMed:11735225"
FT                   /id="VAR_053547"
FT   MUTAGEN         476..477
FT                   /note="FY->AA: Loss of interaction with MOSPD2."
FT                   /evidence="ECO:0000269|PubMed:29858488"
FT   CONFLICT        735
FT                   /note="T -> A (in Ref. 4; AK001079)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        841
FT                   /note="P -> S (in Ref. 1; AAL40662)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        844
FT                   /note="A -> G (in Ref. 1; AAL40662)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..15
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           18..28
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   TURN            29..31
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   TURN            44..46
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           51..58
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           61..69
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           84..90
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           94..102
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           117..120
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   HELIX           124..137
FT                   /evidence="ECO:0007744|PDB:6IYB"
FT   STRAND          544..546
FT                   /evidence="ECO:0007744|PDB:5ZM6"
FT   HELIX           549..557
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          558..560
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           568..570
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          571..575
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           576..581
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           582..584
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            585..587
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           588..594
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           599..613
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           614..617
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          622..625
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          632..637
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            638..641
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          642..650
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            651..654
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          655..662
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          665..680
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          683..690
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          692..696
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           697..699
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          701..705
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          709..718
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          721..732
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            733..735
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          738..743
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           748..750
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            751..754
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          755..761
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          767..774
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            775..777
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          778..782
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           784..792
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          831..835
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           843..845
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            846..848
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           851..856
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           861..864
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           872..874
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           876..882
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           886..909
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          917..923
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   TURN            925..927
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   STRAND          930..934
FT                   /evidence="ECO:0007744|PDB:5ZM5"
FT   HELIX           938..940
FT                   /evidence="ECO:0007744|PDB:5ZM5"
SQ   SEQUENCE   950 AA;  108470 MW;  CDDA26CA27B65F63 CRC64;
     MNTEAEQQLL HHARNGNAEE VRQLLETMAR NEVIADINCK GRSKSNLGWT PLHLACYFGH
     RQVVQDLLKA GAEVNVLNDM GDTPLHRAAF TGRKELVMLL LEYNADTTIV NGSGQTAKEV
     THAEEIRSML EAVERTQQRK LEELLLAAAR EGKTTELTAL LNRPNPPDVN CSDQLGNTPL
     HCAAYRAHKQ CALKLLRSGA DPNLKNKNDQ KPLDLAQGAE MKHILVGNKV IYKALKRYEG
     PLWKSSRFFG WRLFWVVLEH GVLSWYRKQP DAVHNIYRQG CKHLTQAVCT VKSTDSCLFF
     IKCFDDTIHG FRVPKNSLQQ SREDWLEAIE EHSAYSTHYC SQDQLTDEEE EDTVSAADLK
     KSLEKAQSCQ QRLDREISNF LKMIKECDMA KEMLPSFLQK VEVVSEASRE TCVALTDCLN
     LFTKQEGVRN FKLEQEQEKN KILSEALETL ATEHHELEQS LVKGSPPASI LSEDEFYDAL
     SDSESERSLS RLEAVTARSF EEEGEHLGSR KHRMSEEKDC GGGDALSNGI KKHRTSLPSP
     MFSRNDFSIW SILRKCIGME LSKITMPVIF NEPLSFLQRL TEYMEHTYLI HKASSLSDPV
     ERMQCVAAFA VSAVASQWER TGKPFNPLLG ETYELVRDDL GFRLISEQVS HHPPISAFHA
     EGLNNDFIFH GSIYPKLKFW GKSVEAEPKG TITLELLEHN EAYTWTNPTC CVHNIIVGKL
     WIEQYGNVEI INHKTGDKCV LNFKPCGLFG KELHKVEGYI QDKSKKKLCA LYGKWTECLY
     SVDPATFDAY KKNDKKNTEE KKNSKQMSTS EELDEMPVPD SESVFIIPGS VLLWRIAPRP
     PNSAQMYNFT SFAMVLNEVD KDMESVIPKT DCRLRPDIRA MENGEIDQAS EEKKRLEEKQ
     RAARKNRSKS EEDWKTRWFH QGPNPYNGAQ DWIYSGSYWD RNYFNLPDIY
//
